Mitchell P. Kopin 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-08 5:13 pm Purchase |
2024-04-29 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Mitchell P. Kopin | 155,589 4.990% |
155,589 (New Position) |
Filing |